BONE EVOLUTION IN PATIENTS TREATED WITH TERIPARATIDE DUE TO OSTEOPOROSIS: NEW RISK OF FRACTURE

被引:0
|
作者
Pons, J. [1 ]
Ilundain, A. I. [2 ]
机构
[1] Hosp Royo Villanova, Zaragoza, Spain
[2] Hosp Clin Univ Lozano Blesa, Zaragoza, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P223
引用
收藏
页码:S309 / S309
页数:1
相关论文
共 50 条
  • [1] RISK OF NEW FRACTURES OVER 4 YEARS IN PATIENTS TREATED WITH TERIPARATIDE DUE TO OSTEOPOROSIS
    Pons, J.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S333 - S333
  • [2] Change in bone mineral density (BMD) and fracture risk reduction in teriparatide-treated women with osteoporosis.
    Chen, P
    Miller, PD
    Delmas, PD
    Misurski, DA
    Krege, JH
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S56 - S57
  • [3] Consistency of fracture risk reduction in Japanese and Caucasian osteoporosis patients treated with teriparatide: a meta-analysis
    Nakamura, Toshitaka
    Tsujimoto, Mika
    Hamaya, Etsuro
    Sowa, Hideaki
    Chen, Peiqi
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2012, 30 (03) : 321 - 325
  • [4] Consistency of fracture risk reduction in Japanese and Caucasian osteoporosis patients treated with teriparatide: a meta-analysis
    Toshitaka Nakamura
    Mika Tsujimoto
    Etsuro Hamaya
    Hideaki Sowa
    Peiqi Chen
    [J]. Journal of Bone and Mineral Metabolism, 2012, 30 : 321 - 325
  • [5] New simulation model for bone formation markers in osteoporosis patients treated with once-weekly teriparatide
    Tanaka, Sakae
    Adachi, Taiji
    Kuroda, Tatsuhiko
    Nakamura, Toshitaka
    Shiraki, Masataka
    Sugimoto, Toshitsugu
    Takeuchi, Yasuhiro
    Saito, Mitsuru
    Bilezikian, John P.
    [J]. BONE RESEARCH, 2014, 2
  • [6] New simulation model for bone formation markers in osteoporosis patients treated with once-weekly teriparatide
    Sakae Tanaka
    Taiji Adachi
    Tatsuhiko Kuroda
    Toshitaka Nakamura
    Masataka Shiraki
    Toshitsugu Sugimoto
    Yasuhiro Takeuchi
    Mitsuru Saito
    John P Bilezikian
    [J]. Bone Research, 2014, 2 (04) : 252 - 258
  • [7] New simulation model for bone formation markers in osteoporosis patients treated with once-weekly teriparatide
    Sakae Tanaka
    Taiji Adachi
    Tatsuhiko Kuroda
    Toshitaka Nakamura
    Masataka Shiraki
    Toshitsugu Sugimoto
    Yasuhiro Takeuchi
    Mitsuru Saito
    John P Bilezikian
    [J]. Bone Research, 2014, (04) - 258
  • [8] TRABECULAR BONE SCORE IN PATIENTS WITH CHRONIC GLUCOCORTICOID OSTEOPOROSIS TREATED WITH ALENDRONATE OR TERIPARATIDE
    Saag, K. G.
    Agnusdei, D.
    Hans, D.
    Kohlmeier, L. A.
    Krohn, K. D.
    Leib, E. S.
    Maclaughlin, E. J.
    See, K.
    Simonelli, C.
    Taylor, K. A.
    Marcus, R.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S84 - S85
  • [9] New simulation model for bone formation markers in osteoporosis patients treated with once-weekly teriparatide
    Sakae Tanaka
    Taiji Adachi
    Tatsuhiko Kuroda
    Toshitaka Nakamura
    Masataka Shiraki
    Toshitsugu Sugimoto
    Yasuhiro Takeuchi
    Mitsuru Saito
    John P Bilezikian
    [J]. Bone Research, 2
  • [10] ADHERENCE IN PATIENTS WITH SEVERE OSTEOPOROSIS TREATED WITH TERIPARATIDE
    Ziller, V.
    Zimmermann, S-P.
    Ziller, M.
    Hadji, P.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 34 - 34